Get started
Author

William Stevens

Observed names: W Stevens, W. Stevens, Will Stevens, William M Stevens
ORCID: 0000-0001-8474-4645
Observed ORCID: 0000-0001-8474-4645
OpenAlex ID: A5010525956
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
2017 · Louise Bowman, Marion Mafham, et al. · American Heart Journal · 106
PDF
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
2021 · The HPS3/TIMI55-REVEAL Collaborative Group, E Sammons, et al. · European Heart Journal · 62
PDF
Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease
2017 · L. Bowman, J.C. Hopewell, et al. · Journal of Vascular Surgery · 55
PDF
The True Colours Remote Symptom Monitoring System: A Decade of Evolution
2019 · Sarah M Goodday, Lauren Atkinson, et al. · Journal of Medical Internet Research · 43
PDF
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
2022 · Sarah Parish, Marion Mafham, et al. · European Heart Journal · 40
PDF
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial–Adjudicated Direct Follow-up Data in the UK
2021 · Charlie Harper, Marion Mafham, et al. · JAMA Network Open · 33
PDF
Effects of Omega-3 Fatty Acid Supplements on Arrhythmias
2020 · Sarah Parish, Marion Mafham, et al. · Circulation · 27
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
2017 · on behalf of the SHARP Collaborative Group, C. Reith, et al. · BMC Nephrology · 16
PDF
ASCEND-Eye
2023 · Emily L. Sammons, Georgina Buck, et al. · Ophthalmology · 15
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11
PDF
ASCEND-Eye
2024 · Emily L. Sammons, Georgina Buck, et al. · Ophthalmology · 8
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
2023 · Emily Sammons, Louise Bowman, et al. · Contemporary Clinical Trials Communications · 8
Estimating the Future Burden of Cardiovascular Disease in China and the Potential Value of Universal Lipid and Blood Pressure Control
2016 · W Stevens, D Peneva, et al. · Value in Health · 8
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data
2023 · Charlie Harper, Marion Mafham, et al. · Heart · 7
PDF
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics
2026 · Marion M. Mafham, Mohammed G. Zayed, et al. · American Heart Journal · 2
Long-term follow-up of treatment comparisons in RECOVERY: a randomised, open-label, platform trial for patients hospitalised with COVID-19
2025 · Peter W Horby, Leon Peto, et al. · medRxiv
PDF
Individually tailored prophylaxis in Type 3 von Willebrand Disease patients: efficacy and safety of a von Willebrand Factor concentrate with a low factor VIII content
2013 · Emna Gouider, Kathelijne Peerlinck, et al. · Journal of Thrombosis and Haemostasis
Works count: 17
Citation count: 441
H-index: 10
I10-index: 10
Year
Topic
Type